Synthesis of photoactivable inhibitors of osteoclast vacuolar ATPase
Bioorganic & Medicinal Chemistry, ISSN: 0968-0896, Vol: 11, Issue: 10, Page: 2247-2254
2003
- 28Citations
- 11Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations28
- Citation Indexes28
- 28
- CrossRef23
- Captures11
- Readers11
- 11
Article Description
Amides of (2 Z,4 E )-5-[(5,6-dichloroindol-2-yl)]-2-methoxy- N -[3-[4-[3-(carboxymethoxy)phenyl)] piperazin-1-yl]propyl]-2,4-pentadienamide ( 1 ) and of 5-(5,6-dichloro-2-indolyl)-2-methoxy-2,4-pentadienoic acid ( 2 ) are strong inhibitors of the vacuolar ATPase located on the plasma membrane of osteoclasts. In order to understand which V-ATPase subunit is involved in the interaction with these novel inhibitors, analogues containing a photoactivable group and an iodine atom were designed. A series of alcohols or amines containing the photoactivable trifluoroaziridinophenyl or benzophenone moiety and an iodine atom were linked to the above acids via an ester or amide group. These compounds could be thereafter used as a radioactive photoprobe to label the protein. Whereas the compounds containing the photoactivable groups maintained good inhibitory activity, the introduction of the bulky iodine atom was generally detrimental, decreasing potency significantly. Better results were obtained by linking 3-(4-aminopiperidinomethyl)-3′-iodobenzophenone to 3-ethoxy-4-(2-(5,6-dichlorobenzimidazolyl))benzoic acid to give the corresponding amide 27, that inhibited vacuolar ATP-ase with a IC 50 =140 nM. The feasibility of introducing a radioactive 125 I atom was ascertained by exchanging the iodine with a tributylstannyl group, that was again substituted by iodine.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0968089603001068; http://dx.doi.org/10.1016/s0968-0896(03)00106-8; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0037447910&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/12713834; http://linkinghub.elsevier.com/retrieve/pii/S0968089603001068; http://api.elsevier.com/content/article/PII:S0968089603001068?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0968089603001068?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S0968089603001068; http://dx.doi.org/10.1016/s0968-0896%2803%2900106-8; https://dx.doi.org/10.1016/s0968-0896%2803%2900106-8
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know